Загрузка...
Clinicopathological analysis of PD-L2 expression in colorectal cancer
BACKGROUND: (PD-L2), a ligand of programmed cell death protein 1 (PD-1), is an inhibitory receptor of T cells and activated B cells. Many studies have focused on PD-L1, another ligand of PD-1, and the prognostic significance of PD-L1 has been reported in many tumors. However, the expression of PD-L2...
Сохранить в:
| Опубликовано в: : | Onco Targets Ther |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6219115/ https://ncbi.nlm.nih.gov/pubmed/30464512 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S177329 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|